1.	Gynaecological Follow-up of a Subset of 580299/008 (NCT 00122681) Study Subjects Phase: Phase III Type: Screening Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 112024, NCT00937950
2.	Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects Phase: Phase III Type: Screening Status: Active Age: 28 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 113617, NCT01190176
3.	Early Detection of Breast Cancer and Cervical Cancer in Women in India. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II Type: Educational/Counseling/Training, Screening Status: Active Age: 35 to 64 Sponsor: NCI Protocol IDs: TATA-1900215717A1, 1900215717A1, NCT00632047
4.	Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection Phase: Phase II Type: Screening Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: BCCR-H09-03303, P01CA082710, H09-03303, NCT01094132
5.	Specimen and Data Study for Ovarian Cancer Early Detection and Prevention Phase: No phase specified Type: Biomarker/Laboratory analysis, Screening Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 99G8, P30CA060553, NCI-G00-1753, NU-99G7, NCT00005095
6.	The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being Phase: No phase specified Type: Biomarker/Laboratory analysis, Screening Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 9100208476, NCT00155792
7.	HPV Testing for Cervical Cancer Screening Study Phase: No phase specified Type: Health services research, Screening Status: Active Age: 25 to 69 Sponsor: Other Protocol IDs: H06-04032, NCT00461760
8.	Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis Phase: No phase specified Type: Screening Status: Approved-not yet active Age: 25 to 65 Sponsor: Other Protocol IDs: 320.6740, NCT00889902
9.	HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CIN Phase: No phase specified Type: Screening Status: Active Age: 30 to 60 Sponsor: Other Protocol IDs: UW09-377, NCT01058460
10.	A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study Phase: No phase specified Type: Health services research, Prevention, Screening Status: Active Age: 18 to 26 Sponsor: Other Protocol IDs: 33249, NCT01133509
11.	Early Detection of Cancers in Low Resource Countries Phase: No phase specified Type: Diagnostic, Screening Status: Approved-not yet active Age: 30 to 64 Sponsor: Other Protocol IDs: WCF-2011-BRA-IND-CAM, NCT01178736
12.	Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer Phase: No phase specified Type: Health services research, Screening Status: Active Age: 30 to 70 Sponsor: Other Protocol IDs: PI10/01275, NCT01373723
13.	Randomized Implementation of Primary Human Papillomavirus (HPV) Testing in the Organized Screening for Cervical Cancer in Stockholm Phase: No phase specified Type: Screening Status: Approved-not yet active Age: 56 to 65 Sponsor: Other Protocol IDs: SLL-KI-HPV, NCT01511328
14.	Home Human Papillomavirus or Pap Exam (HOPE) Study Phase: No phase specified Type: Diagnostic, Health services research, Screening Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: 7489, R01CA157469, UWCC-7489, FHCRC-7489, NCT01550783
15.	Cervical Cancer Screening Project Part C Phase: No phase specified Type: Screening Status: Active Age: 25 to 70 Sponsor: Other Protocol IDs: 2010NTLS097, NCT01575444
16.	New Methods of Distribution of a Self Sampler Kit for Cervical Cancer Screening Phase: No phase specified Type: Screening Status: Approved-not yet active Age: 35 to 64 Sponsor: Other Protocol IDs: NMD2TE, NCT01647724
17.	HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study Phase: No phase specified Type: Natural history/Epidemiology, Screening Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PapilloV, NCT01792973